{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:31:24Z","timestamp":1772569884458,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Endocrine Society of India","award":["TG2019015\/18-10-2019"],"award-info":[{"award-number":["TG2019015\/18-10-2019"]}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["JIP\/Res\/Intramural\/Phs 2 \/2018\u20132019"],"award-info":[{"award-number":["JIP\/Res\/Intramural\/Phs 2 \/2018\u20132019"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03432-5","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T07:01:58Z","timestamp":1687849318000},"page":"171-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of a single dose of zoledronic acid on bone mineral density and trabecular bone score in Indian postmenopausal osteoporotic women with and without type 2 diabetes mellitus \u2013 A prospective cohort pilot study"],"prefix":"10.1007","volume":"82","author":[{"given":"Chandhana","family":"Merugu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8805-143X","authenticated-orcid":false,"given":"Jayaprakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadishkumar","family":"Kamalanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govindarajalou","family":"Ramkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagili Vijaya Bhaskar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitanshu Sekhar","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dukhabandhu","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niya","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"12","key":"3432_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"O. Johnell, J.A. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 17(12), 1726\u20131733 (2006). https:\/\/doi.org\/10.1007\/s00198-006-0172-4","journal-title":"Osteoporos Int."},{"key":"3432_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S2213-8587(18)30204-3","volume":"6","author":"AP Hills","year":"2018","unstructured":"A.P. Hills, R. Arena, K. Khunti, C.S. Yajnik, R. Jayawardena, C.J. Henry, S.J. Street, M.J. Soares, A. Misra, Epidemiology and determinants of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol. 6, 966\u2013978 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(18)30204-3","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"3432_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"R. Eastell, C.J. Rosen, D.M. Black, A.M. Cheung, M.H. Murad, D. Shoback, Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 104(5), 1595\u20131622 (2019). https:\/\/doi.org\/10.1210\/jc.2019-00221","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3432_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"P. Barrionuevo, E. Kapoor, N. Asi, F. Alahdab, K. Mohammed, K. Benkhadra, J. Almasri, W. Farah, M. Sarigianni, K. Muthusamy, A. Al Nofal, Q. Haydour, Z. Wang, M.H. Murad, Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis. J. Clin. Endocrinol. Metab. 104(5), 1623\u20131630 (2019). https:\/\/doi.org\/10.1210\/jc.2019-00192","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3432_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis. Osteoporos Int. 18(4), 427\u2013444 (2007). https:\/\/doi.org\/10.1007\/s00198-006-0253-4","journal-title":"Osteoporos Int."},{"issue":"6","key":"3432_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4103\/2230-8210.140268","volume":"18","author":"S Kamalanathan","year":"2014","unstructured":"S. Kamalanathan, V. Nambiar, V. Shivane, T. Bandgar, P. Menon, N. Shah, Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus. Indian J. Endocrinol. Metab. 18(6), 831\u2013837 (2014). https:\/\/doi.org\/10.4103\/2230-8210.140268","journal-title":"Indian J. Endocrinol. Metab."},{"key":"3432_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fendo.2013.00072","volume":"4","author":"M Saito","year":"2013","unstructured":"M. Saito, K. Marumo, Bone quality in diabetes. Front. Endocrinol. (Lausanne) 4, 72 (2013). https:\/\/doi.org\/10.3389\/fendo.2013.00072","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"3432_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","volume":"17","author":"S Khosla","year":"2021","unstructured":"S. Khosla, P. Samakkarnthai, D.G. Monroe, J.N. Farr, Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 17(11), 685\u2013697 (2021). https:\/\/doi.org\/10.1038\/s41574-021-00555-5","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"3432_CR9","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00198-019-05053-z","volume":"30","author":"LT Ho-Pham","year":"2019","unstructured":"L.T. Ho-Pham, T.V. Nguyen, Association between trabecular bone score and type 2 diabetes: a quantitative update of the evidence. Osteoporos Int. 30(10), 2079\u20132085 (2019). https:\/\/doi.org\/10.1007\/s00198-019-05053-z","journal-title":"Osteoporos Int."},{"issue":"3","key":"3432_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jbmr.1775","volume":"28","author":"AW Popp","year":"2013","unstructured":"A.W. Popp, S. Guler, O. Lamy, C. Senn, H. Buffat, R. Perrelet, D. Hans, K. Lippuner, Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. J. Bone Miner. Res. 28(3), 449\u2013454 (2013). https:\/\/doi.org\/10.1002\/jbmr.1775","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"3432_CR11","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"K. Hygum, J. Starup-Linde, T. Harsl\u00f8f, P. Vestergaard, B.L. Langdahl, MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur. J. Endocrinol. 176(3), R137\u2013R157 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0652","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3432_CR12","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.bbrc.2018.10.059","volume":"505","author":"W Dong","year":"2018","unstructured":"W. Dong, M. Qi, Y. Wang, X. Feng, H. Liu, Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway. Biochem. Biophys. Res. Commun. 505(4), 1195\u20131202 (2018). https:\/\/doi.org\/10.1016\/j.bbrc.2018.10.059","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3432_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","volume":"60","author":"P Anagnostis","year":"2018","unstructured":"P. Anagnostis, S.A. Paschou, N.N. Gkekas, A.-M. Artzouchaltzi, K. Christou, D. Stogiannou, A. Vryonidou, M. Potoupnis, D.G. Goulis, Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review. Endocrine. 60, 373\u2013383 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1548-x","journal-title":"Endocrine."},{"key":"3432_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","volume":"27","author":"THM Keegan","year":"2004","unstructured":"T.H.M. Keegan, A.V. Schwartz, D.C. Bauer, D.E. Sellmeyer, J.L. Kelsey; fracture intervention trial, Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: The fracture intervention trial. Diabetes Care 27, 1547\u20131553 (2004). https:\/\/doi.org\/10.2337\/diacare.27.7.1547","journal-title":"Diabetes Care"},{"issue":"8","key":"3432_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1359\/JBMR.040325","volume":"19","author":"CH Chesnut 3rd","year":"2004","unstructured":"C.H. Chesnut 3rd, A. Skag, C. Christiansen, R. Recker, J.A. Stakkestad, A. Hoiseth, D. Felsenberg, H. Huss, J. Gilbride, R.C. Schimmer, P.D. Delmas; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE), Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J. Bone Miner. Res. 19(8), 1241\u20131249 (2004). https:\/\/doi.org\/10.1359\/JBMR.040325","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"3432_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01010-w","volume":"22","author":"J Kim","year":"2022","unstructured":"J. Kim, K.M. Kim, S. Lim, M.I. Kang, K.H. Baek, Y.K. Min, Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial. BMC Endocr. Disord. 22(1), 99 (2022). https:\/\/doi.org\/10.1186\/s12902-022-01010-w","journal-title":"BMC Endocr. Disord."},{"issue":"5","key":"3432_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJM200102013440503","volume":"344","author":"MR McClung","year":"2001","unstructured":"M.R. McClung, P. Geusens, P.D. Miller, H. Zippel, W.G. Bensen, C. Roux, S. Adami, I. Fogelman, T. Diamond, R. Eastell, P.J. Meunier, J.Y. Reginster; Hip Intervention Program Study Group, Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N. Engl. J. Med. 344(5), 333\u2013340 (2001). https:\/\/doi.org\/10.1056\/NEJM200102013440503","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"3432_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40200-018-0359-1","volume":"17","author":"V Yilmaz","year":"2018","unstructured":"V. Yilmaz, E. Umay, I. Gundogdu, N. Tezel, Effect of type 2 diabetes mellitus on treatment outcomes of patients with postmenopausal osteoporosis: a retrospective study. J Diabetes Metab. Disord. 17(2), 181\u2013187 (2018). https:\/\/doi.org\/10.1007\/s40200-018-0359-1","journal-title":"J Diabetes Metab. Disord."},{"key":"3432_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/BF02877778","volume":"24","author":"S Dagdelen","year":"2007","unstructured":"S. Dagdelen, D. Sener, M. Bayraktar, Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis. Adv. Ther. 24, 1314\u20131320 (2007). https:\/\/doi.org\/10.1007\/BF02877778","journal-title":"Adv. Ther."},{"issue":"18","key":"3432_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"D.M. Black, P.D. Delmas, R. Eastell, I.R. Reid, S. Boonen, J.A. Cauley, F. Cosman, P. Lakatos, P.C. Leung, Z. Man, C. Mautalen, P. Mesenbrink, H. Hu, J. Caminis, K. Tong, T. Rosario-Jansen, J. Krasnow, T.F. Hue, D. Sellmeyer, E.F. Eriksen, S.R. Cummings; HORIZON Pivotal Fracture Trial, Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N. Engl. J. Med. 356(18), 1809\u20131822 (2007). https:\/\/doi.org\/10.1056\/NEJMoa067312","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"3432_CR21","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/jbmr.4697","volume":"37","author":"R Eastell","year":"2022","unstructured":"R. Eastell, E. Vittinghoff, L.Y. Lui, S.K. Ewing, A.V. Schwartz, D.C. Bauer, D.M. Black, M.L. Bouxsein, Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk. J. Bone Miner. Res. 37(11), 2121\u20132131 (2022). https:\/\/doi.org\/10.1002\/jbmr.4697","journal-title":"J. Bone Miner. Res."},{"key":"3432_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/cen.12495","volume":"81","author":"S Shetty","year":"2014","unstructured":"S. Shetty, N. Kapoor, D. Naik, H.S. Asha, N. Thomas, T.V. Paul, The impact of the Hologic vs the ICMR database in diagnosis of osteoporosis among South Indian subjects. Clin. Endocrinol. (Oxf) 81, 519\u2013522 (2014). https:\/\/doi.org\/10.1111\/cen.12495","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"19","key":"3432_CR23","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMp1608005","volume":"375","author":"JE Manson","year":"2016","unstructured":"J.E. Manson, P.M. Brannon, C.J. Rosen, C.L. Taylor, Vitamin D Deficiency - Is There Really a Pandemic? N. Engl. J. Med. 375(19), 1817\u20131820 (2016). https:\/\/doi.org\/10.1056\/NEJMp1608005","journal-title":"N. Engl. J. Med."},{"key":"3432_CR24","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association, 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care 44, S15\u2013S33 (2021). https:\/\/doi.org\/10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"issue":"9","key":"3432_CR25","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00198-017-4082-4","volume":"28","author":"P Szulc","year":"2017","unstructured":"P. Szulc, K. Naylor, N.R. Hoyle, R. Eastell, E.T. Leary; National Bone Health Alliance Bone Turnover Marker Project, Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos. Int. 28(9), 2541\u20132556 (2017). https:\/\/doi.org\/10.1007\/s00198-017-4082-4","journal-title":"Osteoporos. Int."},{"key":"3432_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"H.K. Genant, C.Y. Wu, C. van Kuijk, M.C. Nevitt, Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8, 1137\u20131148 (1993). https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J. Bone Miner. Res."},{"key":"3432_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","volume":"18","author":"JA Shepherd","year":"2015","unstructured":"J.A. Shepherd, J.T. Schousboe, S.B. Broy, K. Engelke, W.D. Leslie, Executive Summary of the 2015 ISCD Position Development Conference on Advanced Measures from DXA and QCT: Fracture Prediction Beyond BMD. J. Clin. Densitometry 18, 274\u2013286 (2015). https:\/\/doi.org\/10.1016\/j.jocd.2015.06.013","journal-title":"J. Clin. Densitometry"},{"key":"3432_CR28","unstructured":"www.iscd.org \/ resources \/ calculators \/ precision-calculator Accessed 26 Feb 2023"},{"key":"3432_CR29","unstructured":"Medimaps. T.B.S. iNsight to boost your DXA The bone quality assessment. 1\u201312. Available from: https:\/\/www.medimapsgroup.com\/doc\/white-paper\/ Accessed 26 Feb 2023"},{"issue":"2","key":"3432_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1359\/JBMR.051018","volume":"21","author":"DC Bauer","year":"2006","unstructured":"D.C. Bauer, P. Garnero, M.C. Hochberg, A. Santora, P. Delmas, S.K. Ewing, D.M. Black; Fracture Intervention Research Group, Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J. Bone Miner. Res. 21(2), 292\u2013299 (2006). https:\/\/doi.org\/10.1359\/JBMR.051018","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"3432_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jbmr.2361","volume":"30","author":"R Eastell","year":"2015","unstructured":"R. Eastell, S. Boonen, F. Cosman, I.R. Reid, L. Palermo, S.R. Cummings, D.M. Black, Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J. Bone Miner. Res. 30(3), 570\u2013574 (2015). https:\/\/doi.org\/10.1002\/jbmr.2361","journal-title":"J. Bone Miner. Res."},{"key":"3432_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/bonekey.2014.24","volume":"3","author":"M Pazianas","year":"2014","unstructured":"M. Pazianas, S. van der Geest, P. Miller, Bisphosphonates and bone quality. Bonekey Rep. 3, 529 (2014). https:\/\/doi.org\/10.1038\/bonekey.2014.24","journal-title":"Bonekey Rep."},{"key":"3432_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","volume":"91","author":"AV Schwartz","year":"2016","unstructured":"A.V. Schwartz, I. Pavo, J. Alam, D.P. Disch, D. Schuster, J.M. Harris, J.H. Krege, Teriparatide in patients with osteoporosis and type 2 diabetes. Bone. 91, 152\u2013158 (2016). https:\/\/doi.org\/10.1016\/j.bone.2016.06.017","journal-title":"Bone."},{"key":"3432_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","volume":"116","author":"BL Langdahl","year":"2018","unstructured":"B.L. Langdahl, S. Silverman, S. Fujiwara, K. Saag, N. Napoli, S. Soen, H. Enomoto, T.E. Melby, D.P. Disch, F. Marin, J.H. Krege, Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Bone. 116, 58\u201366 (2018). https:\/\/doi.org\/10.1016\/j.bone.2018.07.013","journal-title":"Bone."},{"key":"3432_CR35","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"I.R. Reid, G.D. Gamble, P. Mesenbrink, P. Lakatos, D.M. Black, Characterization of and risk factors for the acute-phase response after zoledronic acid. J. Clin. Endocrinol. Metab. 95, 4380\u20134387 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0597","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3432_CR36","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.bone.2012.02.006","volume":"50","author":"AD Anastasilakis","year":"2012","unstructured":"A.D. Anastasilakis, S.A. Polyzos, P. Makras, G.T. Sakellariou, I. Bisbinas, A. Gkiomisi, S. Delaroudis, S. Gerou, I. Ballaouri, D. Oikonomou, S.E. Papapoulos, Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass. Bone. 50(5), 1130\u20131134 (2012)","journal-title":"Bone."},{"issue":"11","key":"3432_CR37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1507\/endocrj.EJ11-0039","volume":"58","author":"H Karga","year":"2011","unstructured":"H. Karga, I. Giagourta, G. Papaioannou, P. Katsichti, A. Pardalakis, G. Kassi, A. Zagoreou, M. Triantaphyllopoulou, C. Zerva, Transient changes in thyroid functions tests after zoledronic acid infusion. Endocr J 58(11), 969\u2013977 (2011)","journal-title":"Endocr J"},{"issue":"1","key":"3432_CR38","doi-asserted-by":"publisher","first-page":"OC04-6","DOI":"10.7860\/JCDR\/2016\/17061","volume":"10","author":"P Kotian","year":"2016","unstructured":"P. Kotian, A. Boloor, S. Sreenivasan, Study of adverse effect profile of parenteral Zoledronic acid in female patients with osteoporosis. J. Clin. Diagn. Res. 10(1), OC04-6 (2016). https:\/\/doi.org\/10.7860\/JCDR\/2016\/17061","journal-title":"J. Clin. Diagn. Res."},{"issue":"5","key":"3432_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"A. Berbudi, N. Rahmadika, A.I. Tjahjadi, R. Ruslami, Type 2 Diabetes and its Impact on the Immune System. Curr. Diabetes Rev. 16(5), 442\u2013449 (2020). https:\/\/doi.org\/10.2174\/1573399815666191024085838","journal-title":"Curr. Diabetes Rev."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03432-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T08:25:49Z","timestamp":1693211149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03432-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03432-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki after obtaining the Institute Ethics Committee\u2019s approval (JIP\/IEC\/2018\/379 date-28.12.2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}